SK284689B6 - Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom - Google Patents

Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom Download PDF

Info

Publication number
SK284689B6
SK284689B6 SK1197-2000A SK11972000A SK284689B6 SK 284689 B6 SK284689 B6 SK 284689B6 SK 11972000 A SK11972000 A SK 11972000A SK 284689 B6 SK284689 B6 SK 284689B6
Authority
SK
Slovakia
Prior art keywords
benzopyrano
dihydro
trimethyl
quinoline
methoxy
Prior art date
Application number
SK1197-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK11972000A3 (sk
Inventor
Michael J. Coughlan
Steven W. Elmore
Michael E. Kort
Philip R. Kym
Jimmie L. Moore
John K. Pratt
Alan X. Wang
James P. Edwards
Todd K. Jones
Original Assignee
Abbott Laboratories
Ligand Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories, Ligand Pharmaceuticals, Inc. filed Critical Abbott Laboratories
Publication of SK11972000A3 publication Critical patent/SK11972000A3/sk
Publication of SK284689B6 publication Critical patent/SK284689B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SK1197-2000A 1998-02-13 1999-02-12 Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom SK284689B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2394798A 1998-02-13 1998-02-13
US24783199A 1999-02-10 1999-02-10
PCT/US1999/003127 WO1999041256A1 (en) 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents

Publications (2)

Publication Number Publication Date
SK11972000A3 SK11972000A3 (sk) 2001-08-06
SK284689B6 true SK284689B6 (sk) 2005-09-08

Family

ID=26697833

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1197-2000A SK284689B6 (sk) 1998-02-13 1999-02-12 Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom

Country Status (21)

Country Link
EP (1) EP1053239B1 (ko)
JP (1) JP2002503665A (ko)
KR (1) KR20010040935A (ko)
CN (1) CN1119348C (ko)
AT (1) ATE230749T1 (ko)
AU (1) AU766441B2 (ko)
BG (1) BG64317B1 (ko)
BR (1) BR9907788A (ko)
CA (1) CA2320943A1 (ko)
DE (1) DE69904804T2 (ko)
DK (1) DK1053239T3 (ko)
ES (1) ES2192035T3 (ko)
HK (1) HK1033308A1 (ko)
HU (1) HUP0100460A3 (ko)
IL (1) IL137508A0 (ko)
NO (1) NO20004053L (ko)
NZ (1) NZ506013A (ko)
PL (1) PL193323B1 (ko)
SK (1) SK284689B6 (ko)
TR (1) TR200003094T2 (ko)
WO (1) WO1999041256A1 (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506766B1 (en) 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
CO5180649A1 (es) * 1999-09-01 2002-07-30 Abbott Lab Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
US6436986B1 (en) 1999-09-01 2002-08-20 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6593480B2 (en) * 1999-09-01 2003-07-15 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6329534B1 (en) 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
EP1201660B1 (en) 2000-10-30 2005-08-31 Pfizer Products Inc. Glucocorticoid receptor modulators
WO2003002548A1 (en) * 2001-06-29 2003-01-09 Abbott Laboratories A process for the preparation of chiral glucocorticoid receptor agents
US6608216B2 (en) 2001-06-29 2003-08-19 Abbott Laboratories Process for the preparation of chiral glucocorticoid receptor agents
US6518430B1 (en) * 2001-09-21 2003-02-11 Abbott Laboratories Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
AU2003202216A1 (en) 2002-01-14 2003-07-30 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
EP1490317A1 (en) 2002-03-26 2004-12-29 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DK1490062T3 (da) 2002-03-26 2008-04-28 Boehringer Ingelheim Pharma Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf
WO2003086294A2 (en) 2002-04-11 2003-10-23 Merck & Co., Inc. 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US6858627B2 (en) 2002-08-21 2005-02-22 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CL2003001544A1 (es) * 2002-10-11 2005-01-07 Ligand Pharm Inc Compuestos derivados de 5-cicloalquenil-5h-cromeno[3,4-f]quinolina de formula i, moduladores selectivos del receptor de progesterona; composicion farmaceutica; y su uso en el tratamiento de sangrado uterino disfuncional, dismenorrea, endometriosis, l
DE20301728U1 (de) * 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
AR040783A1 (es) * 2002-10-11 2005-04-20 Ligand Pharm Inc 5-(1',1'-cicloaquil/alquenil) metiliden-1,2 -dihidro-5-h-cromeno [3,4- f] quiinolinas como compuestos moduladores selectivos de receptores de progesterona
WO2004063163A1 (en) 2003-01-03 2004-07-29 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20070088042A1 (en) 2004-09-09 2007-04-19 Meissner Robert S Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
WO2005040145A1 (en) 2003-10-16 2005-05-06 Boehringer Ingelheim Pharmaceuticals, Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
JP2008525525A (ja) 2004-12-27 2008-07-17 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメティクス、その製法、医薬組成物及び使用
CA2621292C (en) * 2005-09-14 2014-05-27 Santen Pharmaceutical Co., Ltd. 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity
TW201111392A (en) 2009-06-16 2011-04-01 Schering Corp Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
CA2769563A1 (en) 2009-07-31 2011-02-10 Cadila Healthcare Limited Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1382597A3 (en) * 1994-12-22 2004-04-07 Ligand Pharmaceuticals, Inc. Steroid receptor modulator compounds and methods

Also Published As

Publication number Publication date
NZ506013A (en) 2003-03-28
ATE230749T1 (de) 2003-01-15
BG64317B1 (bg) 2004-09-30
CN1119348C (zh) 2003-08-27
DK1053239T3 (da) 2003-04-22
ES2192035T3 (es) 2003-09-16
EP1053239A1 (en) 2000-11-22
KR20010040935A (ko) 2001-05-15
JP2002503665A (ja) 2002-02-05
HK1033308A1 (en) 2001-08-24
CN1296486A (zh) 2001-05-23
EP1053239B1 (en) 2003-01-08
WO1999041256A1 (en) 1999-08-19
PL343018A1 (en) 2001-07-30
HUP0100460A3 (en) 2003-03-28
DE69904804T2 (de) 2003-11-06
BG104719A (en) 2001-05-31
BR9907788A (pt) 2001-10-30
HUP0100460A2 (hu) 2001-09-28
AU766441B2 (en) 2003-10-16
NO20004053D0 (no) 2000-08-11
NO20004053L (no) 2000-09-11
SK11972000A3 (sk) 2001-08-06
PL193323B1 (pl) 2007-02-28
AU2677399A (en) 1999-08-30
DE69904804D1 (de) 2003-02-13
TR200003094T2 (tr) 2001-01-22
CA2320943A1 (en) 1999-09-19
IL137508A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
SK284689B6 (sk) Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom
US6951942B2 (en) Glucocorticoid-selective anti-inflammatory agents
JP5057273B2 (ja) イソインドリン−1−ワン誘導体
DE60305446T4 (de) Desazapurine und deren verwendung
EP2041142B1 (de) Spirocyclische azaindol-derivate
JPH08511238A (ja) ▲iv▼型ホスホジエステラーゼ阻害因子としてのキノリン類
CN111032034A (zh) 螺环化合物及其制造和使用方法
CN115403570A (zh) μ-阿片受体激动剂及其制备方法和在医药领域的应用
CA3046212A1 (en) Heterocyclic inhibitors of mct4
CA3172478A1 (en) Bcl-2 inhibitor
US20230128062A1 (en) Azabicyclic substituted oxaspiro derivative, preparation method therefor and medical use thereof
JP2023539194A (ja) Apol1の阻害剤およびこれを使用する方法
KR20220141331A (ko) P2x3 조정제
US20230018615A1 (en) Steroids and methods of manufacture
JP2002508359A (ja) 複素環式細胞毒性剤
KR20000070756A (ko) 동맥경화증 및 지단백질과잉혈증 치료에 사용되는 2-아미노 치환된 피리딘
DE10250687A1 (de) 7H-Dibenzo(b,g)(1,5)dioxocin-5-on-Derivate und ihre Verwendung
CZ20002893A3 (cs) Glukokortikoidně selektivní protizánětlivé látky
CA2362272A1 (en) Spirocyclic ketones and their use as tachykinin antagonists
MXPA00007944A (en) Glucocorticoid-selective anti-inflammatory agents
CA2968090A1 (en) 4h-pyrido[1,2-a]pyrimidin-4-one compounds
WO2024006977A1 (en) Analgesic delta opioid receptor bitopic ligands
WO2013149996A9 (en) Substituted tricyclic compounds with activity towards ep1 receptors
JPS63253055A (ja) ヒドロフルオレン誘導体
JPS58174337A (ja) 置換ドデカヒドロトリフェニレン類